Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality

Prevalence, Resistance Mechanisms, and Susceptibility of Multidrug-Resistant Bloodstream Isolates of Pseudomonas aeruginosa

(2010) V. H. Tam et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Impact of Multidrug-Resistant Pseudomonas aeruginosa Bacteremia on Patient Outcomes

(2010) V. H. Tam et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Gram‐Negative Bacteremia upon Hospital Admission: When ShouldPseudomonasaeruginosaBe Suspected?

(2009) Vered Schechner et al.   CLINICAL INFECTIOUS DISEASES

Factors associated with mortality in bacteremic patients with hematologic malignancies

(2009) Mario Tumbarello et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Clinical Significance and Predictors of Community-Onset Pseudomonas aeruginosa Bacteremia

(2008) Hae Suk Cheong et al.   AMERICAN JOURNAL OF MEDICINE

Inappropriate initial antimicrobial therapy as a risk factor for mortality in patients with community-onset Pseudomonas aeruginosa bacteraemia

(2008) H. S. Cheong et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Epidemiology of bacteremia episodes in a single center: increase in Gram-negative isolates, antibiotics resistance, and patient age

(2008) D. Marchaim et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES